MEZKIXUS

What this means for you

Not registered yet, but its 05 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99480962

Mark type

Stylized text

Filed

05 Nov 2025

Attorney of record

Marilyn F. Kelly

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Pharmaceutical preparations for the treatment and prevention of Antivirals;; Pharmaceutical preparations for the treatment and prevention of Antibodies for medical purposes;; Pharmaceutical preparations for the treatment and prevention of Anticoagulants;; Pharmaceutical preparations for the treatment and prevention of Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Pharmaceutical preparations for the treatment and prevention of Diagnostic radiopharmaceutical preparations;; Pharmaceutical preparations for the treatment and prevention of Diagnostic preparations for medical purposes;; Pharmaceutical preparations for the treatment and prevention of Biological preparations for the treatment of cancer;; Pharmaceutical preparations for the treatment and prevention of Stem cells for medical purposes;

Owner

• Celgene Corporation, Princeton, NJ, US

Prosecution history

• 28 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 28 Mar 2026 — NON-FINAL ACTION E-MAILED
• 28 Mar 2026 — NON-FINAL ACTION WRITTEN
• 20 Mar 2026 — ASSIGNED TO EXAMINER
• 19 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 05 Nov 2025 — APPLICATION FILING RECEIPT MAILED
• 05 Nov 2025 — NEW APPLICATION ENTERED